MGI Tech and SeqOne Partner to Advance Genomic Analysis
MGI and SeqOne will collaborate to develop and validate comprehensive genomic analysis solutions for human genetics and pathology labs.
Read MorePosted by Andy Lundin | Jun 17, 2024 | Company News |
MGI and SeqOne will collaborate to develop and validate comprehensive genomic analysis solutions for human genetics and pathology labs.
Read MorePosted by Andy Lundin | Jun 14, 2024 | Diagnostic Technologies |
Researchers have demonstrated that a new technology, u-dHRM, can quickly and accurately diagnose bloodstream infections.
Read MorePosted by Andy Lundin | Jun 14, 2024 | Cancer |
Researchers developed an AI-based method for detecting tumor DNA in blood with high sensitivity, improving prediction of cancer recurrence.
Read MorePosted by Andy Lundin | Jun 10, 2024 | Unknown Origin & Other Cancer Types |
A clinical trial shows that a Helio Genomics test outperforms ultrasound in detecting hepatocellular carcinoma in liver cirrhosis patients.
Read MorePosted by Andy Lundin | Jun 10, 2024 | Flu & Respiratory Infections |
Roche’s cobas liat COVID, Influenza A/B & RSV test, is a rapid RT-PCR assay that detects multiple respiratory viruses from a single sample.
Read More